11:52 AM EST - Oncolytics Biotech Inc. : Announced a clinical collaboration with SOLTI, an academic research group dedicated to clinical and translational research in breast cancer. This clinical collaboration, being sponsored by Oncolytics and facilitated by SOLTI, is a window of opportunity study in the neoadjuvant setting for breast cancer. Oncolytics Biotech Inc.
shares T.ONC are trading down $0.20 at $5.80.
